Pieris Pharmaceuticals, Inc.
(NASDAQ : PIRS)

( )
PIRS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.43%203.201.2%$410.88m
GILDGilead Sciences, Inc.
0.29%73.880.9%$388.27m
CELGCelgene Corporation
-0.26%87.381.2%$331.13m
BIIBBiogen Inc.
0.60%338.911.2%$285.04m
ILMNIllumina, Inc.
-0.15%350.373.5%$238.24m
REGNRegeneron Pharmaceuticals, Inc.
-1.19%383.702.6%$211.99m
EXASExact Sciences Corporation
1.90%74.1425.3%$196.59m
VRTXVertex Pharmaceuticals Incorporated
-0.29%176.601.9%$158.10m
SRPTSarepta Therapeutics, Inc.
-1.06%151.9516.4%$124.69m
AAgilent Technologies, Inc.
0.93%69.571.5%$120.73m
ALXNAlexion Pharmaceuticals, Inc.
0.95%121.972.0%$110.07m
VKTXViking Therapeutics, Inc.
0.98%19.650.9%$100.12m
NKTRNektar Therapeutics
-2.81%56.695.6%$93.69m
ALNYAlnylam Pharmaceuticals, Inc
1.14%94.829.7%$93.23m
BMRNBioMarin Pharmaceutical Inc.
0.21%99.774.4%$92.72m

Company Profile

Pieris Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. It offers technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with an unmet medical need. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.